Bishal Gyawali: Financial Toxicity in Cancer Clinical Trials Linked to Worse Outcomes

Bishal Gyawali, associate professor at Queen’s University, shared a post on LinkedIn:

“We got a new paper for you for your weekend reading. In this new research article in collaboration with CCTG now published in JNCI , we show that among cancer patients participating in clinical trials.

1. More than 1/3 patients have baseline financial difficulty, and this is associated with worse mortality
2. 1/4 patients have worsening of financial difficulty during the trial, and this is associated with worse quality of life

Financial toxicity is not just a policy issue; it is a clinical issue.

Read more here.”

Title: Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of life

Journal: Journal of the National Cancer Institute

Authors: Bishal Gyawali, Nan Chen, Dongsheng Tu, Joseph Pater

Read the full article.

More from Bishal Gyawali on OncoDaily.